Options Trading News

November 27, 2012  Tue 9:58 AM CT

Cell Therapeutics is struggling to gain ground, and one large trader is looking for a floor beneath the stock.

optionMONSTER's systems show that a trader sold 10,000 June 1 puts for the $0.20 on a wide bid/ask spread. There was no previous open interest, so this is a new position.

CTIC is flat on the day at $1.42. The cancer-drug developer was down at $1.14 earlier in the month, its lowest price since gapping up at the start of September from $0.45 to above $2.

The put selling is a bet that that CTIC will remain above the $1 strike price in coming months. The trader faces the possibility of having to buy shares if they are below that level, but at an effective price of $0.80 including the credit from the put sale.  (See our Education section)
Share this article with your friends

Invest Like a Monster - San Antonio: October 9-10

Premium Services

Archived Webinar

Education & Strategy

Options Academy: More on the Covered Call Strategy

Last week, we talked about the Covered Call and the misconceptions that surround it. We spoke about how an investor must realize that the Covered Call is actually a premium collection strategy and not so much a directional one. If an investor can grasp this idea, the investor stands to do a heck of a lot better in the strategy than they currently do.

View more education articles »